Project
2 available projects
DRTB-HDT - Stratified Host-Directed Therapy for Rifampicin-Resistant TB: A Randomized Controlled Multi-Centre Trial
Tuberculosis (TB) has historically been the most common infectious cause of death globally, surpassed only recently (and presumably temporarily) by the ongoing Covid-19 pandemic. TB treatment is lengthy and often unsuccessful. Even if cured, most patients are left with impaired lung function and…
Performance of Cepheid GeneXpert® Omni for early detection of tuberculosis and multidrug resistant tuberculosis in adults with presumptive pulmonary tuberculosis at Primary Health Care facilities in Georgia in a controlled phased pre and post intervention
Tuberculosis (TB) still remains a major global challenge. In 2017, there were estimated10million new cases globally. Same year 16% of people with TB has died from the disease. In the same year, 6.4 million new cases were reported, accounting for only 64% of the total estimated incidence. Due to…